In patients with PD, the levels of DAT binding measured with PET or SPECT will overestimate the true degree of neurodegeneration in the striatum because of a downregulation of DAT expression in the remaining neurons as an adaptive mechanism to preserve synaptic dopamine levels [39,40]. Here, SLC6A3 is linked to Parkinson disease.